First Clinical Publication in Japan for the SpineGuard DSG® Technology

December 16, 2019 

PARIS & BOULDER, Colo.–(BUSINESS WIRE)–Regulatory News:

SpineGuard (Paris:ALSGD) (FR0011464452 – ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, announced today the first clinical publication in Japan for its DSG technology.

This technical note published in Neurologia medico-chirurgica (the official peer-reviewed scientific journal of the Japan Neurosurgical Society) presents the clinical usefulness of PediGuard for an optimal positioning of bi-cortical screws in the lateral mass of the 1st cervical vertebra. These screws require an extremely precise positioning in order to avoid the vertebral artery as well as the internal carotid artery.

Link to publication abstract

Stéphane Bette, CEO of SpineGuard, said: “It is the first scientific publication about our DSG technology in Japan, the 2nd largest market worldwide in our sector1. Furthermore, in a degenerative cervical spine application that requires extreme precision and sensitivity to screw placement, a specialty for Japanese surgeons due to the prevalence of such pathologies in this country. We are thus very happy about this 15th peer-reviewed journal publication documenting the clinical value of our DSG Technology in Spine. It strengthens the solid base of clinical evidence in support of our DSG technology that we are determined to deploy throughout new and promising clinical applications. We are actively working with the venture bank Healthios Capital Markets in order to find significant industry partnerships and generate growth and value for our shareholders.”

Dr. Hiroto Kageyama, Assistant Professor of neurosurgery at Hyogo College of Medicine, Nishinomyia, Hyogo, Japon adds: “We found the PediGuard device useful in our practice for the insertion of C1 lateral mass screws because it is easy to detect the anterior cortical wall of the Atlas on the basis of its auditory signal. After measuring the actual probe length, the screw length can be decided and the bicortical screwing can be performed safely and tightly.”

About SpineGuard®

Founded in 2009 in France and the USA by Pierre Jérôme and Stéphane Bette, SpineGuard is an innovative company deploying its proprietary radiation-free real time sensing technology DSG® (Dynamic Surgical Guidance) to secure and streamline the placement of implants in the skeleton. SpineGuard designs, develops and markets medical devices that have been used in over 75,000 surgical procedures worldwide. Fifteen studies published in peer-reviewed scientific journals have demonstrated the multiple benefits DSG® offers to patients, surgeons, surgical staff and hospitals. Building on these solid fundamentals and several strategic partnerships, SpineGuard has expanded its technology platform in a disruptive innovation: the « smart » pedicle screw launched late 2017 and is broadening the scope of applications in dental implantology and surgical robotics. DSG® was co-invented by Maurice Bourlion, Ph.D., Ciaran Bolger, M.D., Ph.D., and Alain Vanquaethem, Biomedical Engineer.

For further information, visit www.spineguard.com


The SpineGuard securities may not be offered or sold in the United States as they have not been and will not be registered under the Securities Act or any United States state securities laws, and SpineGuard does not intend to make a public offer of its securities in the United States. This is an announcement and not a prospectus, and the information contained herein does and shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the securities referred to herein in the United States in which such offer, solicitation or sale would be unlawful prior to registration or exemption from registration.

1 Source: “Spinal Surgery Devices Market: Global Market Analysis, Dynamics, Country Share, Trends, Competitor Analysis 2013 – 2017 and Forecast 2018 – 2025”, Kenneth Research, Dec. 2019


Stéphane Bette
Chief Executive Officer
Tel: +33 (0)1 45 18 45 19

Manuel Lanfossi
Chief Financial Officer

Europe / NewCap
Investor Relations & Financial Communication
Mathilde Bohin / Pierre Laurent
Tel: +33 (0)1 44 71 94 94

Mike Adams

Mike Adams is a medical device sales leader with extensive clinical experience in spine and biologics and a nationwide distribution network built over the last 10+ years in the industry. He has held various leadership positions in healthcare and device including Distributor Partner, Hospital COO and Spine VP of Sales. He currently leads the commercialization strategy for OrthoSpine Partners and is a Distributor Principal at Novel Medical. Because of his unique career path, Mike has the ability to see the healthcare business from multiple perspectives making him passionate about building strategic partnerships that help reduce overall costs, drive innovation, and cultivate growth for new markets.

Related Articles

Back to top button